August 31, 2015
2 min read
Save

Top read articles in August focus on SLE, RA and fibromyalgia

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The most highly read articles during the month of August on Healio.com/Rheumatology were focused on systemic lupus erythematosus, rheumatoid arthritis and fibromyalgia, among other topics.

Our readers were most interested in thyroid dysfunction in patients with systemic lupus erythematosus (SLE), symptoms in patients with concurrent fibromyalgia and rheumatoid arthritis (RA) and therapeutic advances in RA.

1. Thyroid dysfunction common in patients with SLE

Patients with systemic lupus erythematosus were more likely to have thyroid dysfunction compared with healthy adults, according to recently published research. Read more.

2. Fibromyalgia symptoms may mimic high disease activity in patients with RA

Symptoms of fibromyalgia may mimic high disease activity in patients with RA, according to recently presented data. Read more.

3. Tabalumab fails phase 3 trial in patients with RA

Tabalumab did not meet its primary endpoints in a phase 3 trial of patients with RA, according to the recently published results of a study. Read more.

4. First-degree relatives of patients with HLA-B27 + ankylosing spondyli tis may have undetected disease

First-degree relatives of patients with HLA-B27-positive ankylosing spondylitis were more likely to have undetected symptoms of ankylosing spondylitis that may progress over time, according to results of a study. Read more.

5. Top 7 EULAR articles about RA research focus on biologics

Research presented at the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology, which took place between June 10 and 13 in Rome, focused heavily on RA. Read more.

PAGE BREAK

6. Safety profile of Remsima biosimilar appears to be similar to Remicade in patients with RA, ankylosing spondylitis

A safety profile consistent with that of the historical safety data of Remicade (infliximab, Janssen) was observed among patients with RA and ankylosing spondylitis treated with the Remicade biosimilar, Remsima, according to the results of an analysis. Read more.

7. Cholecalciferol injection may reduce fatigue, musculoskeletal pain in patients with fibromyalgia

Patients with fibromyalgia may have improvements in fatigue and musculoskeletal pain by increasing vitamin D levels through monthly, intramuscular cholecalciferol injection, according to recently presented data. Read more.

8. Neutropenia may occur with Rituxan treatment for RA, autoimmune diseases

Rituxan (rituximab, Genentech) was associated with late-onset neutropenia in some patients with RA and other autoimmune diseases, according to recently published details from a study. Read more.

9 . Depression linked to non adherence to TNF-a inhibitors in patients with ankylosing spondylitis

Depression and anxiety were associated with the discontinuation of tumor necrosis factor-alpha (TNF-a) inhibitors in patients with ankylosing spondylitis, according to recently presented data. Read more.

10. Patients with PsA, spondylitis may benefit from Stelara

Patients with psoriatic arthritis (PsA) and concurrent spondylitis showed improvement in disease activity scores and symptoms, in addition to slowed radiographic progression, while receiving Stelara (ustekinumab, Janssen) for 2 years, according to recently presented research. Read more.